NAM
NERV icon

Nexpoint Asset Management’s Minerva Neurosciences NERV Stock Holding History

Nexpoint Asset Management’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-50,000
Closed -$696K – 226
2021
Q3 		$696K Buy
50,000
+9,975
+25% +$150K 0.12% 85
2021
Q2 		$743K Buy
40,025
+32,136
+407% +$692K 0.16% 80
2021
Q1 		$184K Hold
7,889
– – 0.05% 142
2020
Q4 		$148K Hold
7,889
– – 0.05% 134
2020
Q3 		$201K Hold
7,889
– – 0.05% 142
2020
Q2 		$228K Sell
7,889
-17,267
-69% -$1.01M 0.05% 161
2020
Q1 		$1.21M Sell
25,156
-39,318
-61% -$2.37M 0.23% 62
2019
Q4 		$3.67M Sell
64,474
-33,428
-34% -$1.47M 0.28% 43
2019
Q3 		$6.07M Buy
+97,902
New +$5.54M 0.38% 38

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Nexpoint Asset Management's NERV Position: Q4 2021 in Review

Nexpoint Asset Management sold out of Minerva Neurosciences (NERV) in Q4 2021, closing a stake of 50,000 shares — an estimated $696K sold.

Nexpoint Asset Management first reported a position in NERV in Q3 2019 and held it in 9 quarters. The position peaked at $6.07M in Q3 2019. 35 funds tracked by Wall St. Rank hold NERV as of Q4 2021.

  • Nexpoint Asset Management reported no remaining Minerva Neurosciences position as of Q4 2021 after selling out during the quarter.
  • Nexpoint Asset Management sold 50,000 Minerva Neurosciences shares in Q4 2021, an estimated $696K.
  • Nexpoint Asset Management first reported a position in Minerva Neurosciences in Q3 2019 and held it in 9 quarters.
  • Nexpoint Asset Management's Minerva Neurosciences position peaked at $6.07M in Q3 2019.
  • 35 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2021.

Based on Nexpoint Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.